← SynDRA
ICI-199,441
SynDRA canonical compound SYN0002019 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | OPRK1 |
| Mechanism of action | Opioid receptor agonist |
All known targets
- OPRK1
- OPRM1
- CYP2D6
- OPRD1
- UTS2R
Mechanisms of action (all sources)
- Opioid receptor agonist
- OPRK1 AGONIST
- OPRM1 AGONIST
- UTS2R INHIBITOR
- OPRD1 INHIBITOR
- OPRK1 INHIBITOR
- CYP2D6 INHIBITOR
- OPRM1 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ALDH1A1
- ALOX15B
- CYP1A2
- CYP2C19
- CYP2C9
- CYP3A4
- EHMT2
- GBA1
- HDAC6
- MAPK1
- SMN1
- TDP1
- TP53
- TSHR
- USP1
- VDR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
Cross-references
Synonyms
- 441
- GR-199
- ICI-199441
- Ici 199441
- ICI 199,441 hydrochloride
- Ici 199,441
- AC1MIZCX
- N-(2-(N-Methyl-3,4-dichlorophenylacetamido)-2-phenylethyl)pyrrolidine
- SCHEMBL7647023
- CTK8E9897
- MolPort-023-275-929
- AKOS024458644
- (S)-3,4-Dichloro-N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)benzeneacetamide monohydrochloride
- RT-013313
- B6448
- J-003264
- Benzeneacetamide, 3,4-dichloro-N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-, monohydrochloride, (S)-
- Q5R50X7L6M
- UNII-Q5R50X7L6M
- GR-199441
- GR-199,441
- NCGC00024784-01
- Tocris-0778
- SCHEMBL7640991
- SCHEMBL16340553
- CHEBI:93291
- GTPL11691
- BDBM50007344
- ICI199441
- ligand 1 [PMID: 8893842]
- EBC-373075
- NCGC00024784-02
- BRD-K73290745-003-01-8
- BRD-K73290745-003-02-6
- 2-(3,4-dichlorophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide
- CS-0020983
- orb1704478
- MFCD01074479
- ICI-199441 HCl
Look up ICI-199,441 in the interactive SynDRA portal →